News Image

IceCure's ProSense® Featured at CIRSE 2025 Annual Meeting: Positive Clinical Results with Cryoablation from 4 Independent Studies Presented

Provided By PR Newswire

Last update: Sep 22, 2025

Presentations from 5 Key Opinion Leaders on ProSense® cryoablation including 3 independent studies on breast cancer and 1 on endometriosis   

3 hands-on training sessions for doctors interested in using ProSense® were very well attended

Read more at prnewswire.com

ICECURE MEDICAL LTD

NASDAQ:ICCM (9/26/2025, 8:00:02 PM)

After market: 1.04 +0.02 (+1.96%)

1.02

-0.01 (-0.97%)



Find more stocks in the Stock Screener

Follow ChartMill for more